Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-22 · accession 0001214659-23-004146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-03-23 | 2023-03-22 | ALZN | McGrath Lynne Fahey | Dir | P - Purchase | $0.44 | +10.0K | 10.0K | New | +$4,400 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-22 | P | A | 10,000 | $0.44 | 10,000 | I By Spouse | — | — | (F1) The shares were purchased in an individual retirement account owned by Mrs. McGrath's spouse. Mrs. McGrath disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |